Ossigeno C.I.O. (Oxygen)

Oxygen, the active ingredient in Ossigeno C.I.O., is a medical gas presented as a respiratory support for inhalation use. It provides supplemental oxygen to patients with compromised breathing, helping to maintain adequate tissue oxygenation in a variety of clinical settings.

GNH USA supplies Ossigeno C.I.O. as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Ossigeno C.I.O. is a medical gas used to support patients with conditions that affect oxygenation. - Hypoxemia: improves arterial oxygen saturation and reduces symptoms of low blood oxygen. - Chronic obstructive pulmonary disease (COPD): alleviates dyspnea and enhances exercise tolerance. - Postoperative recovery: supports tissue oxygenation and promotes healing after surgery. - Acute respiratory distress syndrome (ARDS): provides essential supplemental oxygen to maintain adequate gas exchange.

Supplemental oxygen may be associated with a range of adverse reactions, most of which are related to the delivery system or high oxygen concentrations.

Common Side Effects: - Nasal dryness or irritation - Throat discomfort - Headache - Dizziness - Cough - Mild fatigue

Serious or Rare Side Effects: - Pulmonary oxygen toxicity (e.g., atelectasis, fibrosis) - Seizures due to hyperoxia - Fire or explosion hazard in the presence of flammable materials - Vision changes (e.g., myopia) with prolonged high‑concentration exposure - Hypoxemia paradox when flow rates are improperly set

Use of Ossigeno C.I.O. requires careful clinical assessment and monitoring. - Assess baseline oxygen saturation: confirm need for supplemental oxygen before initiation. - Adjust flow rate per physician order: avoid excessive concentrations that may cause toxicity. - Monitor patients with CO₂ retention: watch for worsening hypercapnia. - Use appropriate delivery device: ensure proper fit of masks or nasal cannulae. - Observe for signs of hyperoxia: headache, visual changes, or respiratory distress. - Store at ambient temperature: keep cylinders in a well‑ventilated area, protect from heat and direct sunlight.

Oxygen can interact with certain agents and environmental factors, influencing safety and efficacy.

Major Interactions (Avoid): - Nitrous oxide: increased fire risk when used together. - Flammable inhalational anesthetics (e.g., sevoflurane) in open circuits: heightened combustion hazard. - Smoking or open flames near oxygen delivery: risk of fire or explosion.

Moderate Interactions (Monitor Closely): - Bronchodilators: may enhance bronchodilatory effect, requiring observation. - Carbon monoxide exposure: oxygen therapy can mask CO poisoning symptoms. - Systemic corticosteroids: combined use may increase infection risk, necessitating monitoring.